Clinical trial
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With…
NCT00313456 · Agennix, Industry · Terminated
Key facts
| NCT number | NCT00313456 |
|---|---|
| Title | A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel |
| Official title | A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel |
| Lead sponsor | Agennix, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Satraplatin |
| Enrollment | 25 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 12, 2006 |
| Last update posted | May 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: